119 related articles for article (PubMed ID: 26772958)
1. Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies.
Caorsi C; Niccolai E; Capello M; Vallone R; Chattaragada MS; Alushi B; Castiglione A; Ciccone G; Mautino A; Cassoni P; De Monte L; Álvarez-Fernández SM; Amedei A; Alessio M; Novelli F
Transl Res; 2016 May; 171():17-28.e1-2. PubMed ID: 26772958
[TBL] [Abstract][Full Text] [Related]
2. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
Front Immunol; 2022; 13():837512. PubMed ID: 35401558
[TBL] [Abstract][Full Text] [Related]
3. Expression of protein disulfide isomerase A3 and its clinicopathological association in gastric cancer.
Shimoda T; Wada R; Kure S; Ishino K; Kudo M; Ohashi R; Fujita I; Uchida E; Yoshida H; Naito Z
Oncol Rep; 2019 Apr; 41(4):2265-2272. PubMed ID: 30720117
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies against protein disulfide isomerase ER-60 are a diagnostic marker for low-grade testicular inflammation.
Fijak M; Zeller T; Huys T; Klug J; Wahle E; Linder M; Haidl G; Allam JP; Pilatz A; Weidner W; Schuppe HC; Meinhardt A
Hum Reprod; 2014 Nov; 29(11):2382-92. PubMed ID: 25205753
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.
Milne K; Barnes RO; Girardin A; Mawer MA; Nesslinger NJ; Ng A; Nielsen JS; Sahota R; Tran E; Webb JR; Wong MQ; Wick DA; Wray A; McMurtrie E; Köbel M; Kalloger SE; Gilks CB; Watson PH; Nelson BH
PLoS One; 2008; 3(10):e3409. PubMed ID: 18923710
[TBL] [Abstract][Full Text] [Related]
6. Murine dendritic cells pulsed with an anti-idiotype antibody induce antigen-specific protective antitumor immunity.
Saha A; Chatterjee SK; Foon KA; Primus FJ; Bhattacharya-Chatterjee M
Cancer Res; 2003 Jun; 63(11):2844-54. PubMed ID: 12782590
[TBL] [Abstract][Full Text] [Related]
7. Expression of protein disulfide isomerase A3 precursor in colorectal cancer.
Yang Z; Liu J; Shi Q; Chao Y; Di Y; Sun J; Zhang J; Huang L; Guo H; He C
Onco Targets Ther; 2018; 11():4159-4166. PubMed ID: 30050307
[TBL] [Abstract][Full Text] [Related]
8. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
9. Differential proteomics identifies PDIA3 as a novel chemoprevention target in human colon cancer cells.
Ménoret A; Drew DA; Miyamoto S; Nakanishi M; Vella AT; Rosenberg DW
Mol Carcinog; 2014 Feb; 53 Suppl 1():E11-22. PubMed ID: 23255428
[TBL] [Abstract][Full Text] [Related]
10. The specific immune response to tumor antigen CP1 and its correlation with improved survival in colon cancer patients.
Liu FF; Dong XY; Pang XW; Xing Q; Wang HC; Zhang HG; Li Y; Yin YH; Fant M; Ye YJ; Shen DH; Zhang Y; Wang S; Chen WF
Gastroenterology; 2008 Apr; 134(4):998-1006. PubMed ID: 18395081
[TBL] [Abstract][Full Text] [Related]
11. The role of protein disulphide-isomerase A3 as autoantigen in the pathogenesis of autoimmune thyroiditis and related brain damage in adult mice.
Yang W; Xiang Y; Zhang H; Shan Z; Li J; Teng W
Clin Immunol; 2020 Mar; 212():108350. PubMed ID: 31982645
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Serum Haptoglobin and Protein Disulfide-Isomerase A3 in the Screening, Diagnosis, and Staging of Colorectal Cancer.
Niu Y; Xue J; Wu X; Qu M; Wang L; Liang W; Li T
Front Pharmacol; 2022; 13():935500. PubMed ID: 35860021
[No Abstract] [Full Text] [Related]
13. Differential expression of protein disulfide-isomerase A3 isoforms, PDIA3 and PDIA3N, in human prostate cancer cell lines representing different stages of prostate cancer.
Diaz Cruz MA; Karlsson S; Szekeres F; Faresjö M; Lund D; Larsson D
Mol Biol Rep; 2021 Mar; 48(3):2429-2436. PubMed ID: 33761087
[TBL] [Abstract][Full Text] [Related]
14. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
Kass R; Bellone S; Palmieri M; Canè S; Bignotti E; Henry-Tillman R; Hutchins L; Cannon MJ; Klimberg S; Santin AD
Breast Cancer Res Treat; 2003 Aug; 80(3):275-85. PubMed ID: 14503800
[TBL] [Abstract][Full Text] [Related]
15. Oxidatively Modified Protein-Disulfide Isomerase-Associated 3 Promotes Dyskerin Pseudouridine Synthase 1-Mediated Malignancy and Survival of Hepatocellular Carcinoma Cells.
Ko E; Kim JS; Ju S; Seo HW; Chang Y; Kang JA; Park SG; Jung G
Hepatology; 2018 Nov; 68(5):1851-1864. PubMed ID: 29672884
[TBL] [Abstract][Full Text] [Related]
16. The evolving role of protein disulfide isomerase A3 in Egyptian bladder cancer patients.
Safwat El-Deeb O; Abd-Ellatif RN; Othman TS; Afifi M; El-Magd M
Gene; 2019 Apr; 693():76-83. PubMed ID: 30708028
[TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
Zhang J; Wang K; Hainisayimu T; Li H
Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
[TBL] [Abstract][Full Text] [Related]
18. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.
Schwitalle Y; Kloor M; Eiermann S; Linnebacher M; Kienle P; Knaebel HP; Tariverdian M; Benner A; von Knebel Doeberitz M
Gastroenterology; 2008 Apr; 134(4):988-97. PubMed ID: 18395080
[TBL] [Abstract][Full Text] [Related]
19. Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients.
Benvenuto M; Sileri P; Rossi P; Masuelli L; Fantini M; Nanni M; Franceschilli L; Sconocchia G; Lanzilli G; Arriga R; Faggioni G; Lista F; Orlandi A; Manzari V; Gaspari AL; Modesti A; Bei R
J Transl Med; 2015 Mar; 13():101. PubMed ID: 25889931
[TBL] [Abstract][Full Text] [Related]
20. Protein Disulfide Isomerase A3 (PDIA3): A Pharmacological Target in Glioblastoma?
Paglia G; Minacori M; Meschiari G; Fiorini S; Chichiarelli S; Eufemi M; Altieri F
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
